ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,729Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 1499

$1.51M Total Retail Price of All Prescriptions

Rank: 20 out of 1499

624 Patients Receiving at Least One Drug in Part D
45%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 624 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 624 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,466 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 588 300 1 3
AMLODIPINE BESYLATE 523 367 2 6
CRESTOR 441 179 3 34
ATORVASTATIN CALCIUM 409 229 4 17
METFORMIN HCL 405 253 5 8
FUROSEMIDE 387 239 6 7
LISINOPRIL 339 155 7 1
OMEPRAZOLE 311 140 8 5
LEVOTHYROXINE SODIUM 263 167 9 2
HYDROCHLOROTHIAZIDE 257 155 10 9
CYMBALTA 229 45 11 40
TRAMADOL HCL 222 117 12 16
RANITIDINE HCL 209 78 13 15
VICTOZA 3-PAK 207 46 14 306
DIOVAN HCT 205 120 15 122
BYSTOLIC 195 123 16 108
ACTOPLUS MET 195 66 10 16 309
HYDROCODONE-ACETAMINOPHEN 181 70 S3 18 4
LOVASTATIN 180 100 19 19
MELOXICAM 168 94 20 27
CARVEDILOL 166 65 21 22
PLAVIX 166 80 21 54
EXFORGE HCT 163 99 23 315
TRILIPIX 162 57 24 171
PROAIR HFA 161 79 25 30
JANUVIA 161 113 25 84
LOVAZA 157 17 27 136
ADVAIR DISKUS 156 73 28 37
PEN NEEDLE 154 44 29 120
SPIRIVA 150 81 30 44
NEXIUM 149 71 31 28
METOPROLOL TARTRATE 148 90 32 10
ACTOS 143 84 33 145
BENICAR HCT 143 52 33 310
CLOPIDOGREL 141 67 35 39
LIPITOR 139 81 36 107
PRAVASTATIN SODIUM 136 95 37 18
ALENDRONATE SODIUM 129 114 38 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 58 39 25
LOSARTAN-HYDROCHLOROTHIAZIDE 122 71 40 73
ACETAMINOPHEN-CODEINE 121 76 S3 41 134
NAMENDA 121 112 41 47
BENICAR 121 79 41 211
CELEBREX 118 59 44 77
CITALOPRAM HBR 117 71 45 14
GABAPENTIN 116 61 46 13
ZOLPIDEM TARTRATE 115 52 47 23
LOSARTAN POTASSIUM 105 48 48 26
FENOFIBRATE 101 56 49 66
TAMSULOSIN HCL 100 68 50 29
WARFARIN SODIUM 98 80 51 12
ATENOLOL 96 43 52 21
LEVEMIR FLEXPEN 90 18 53 235
DIOVAN 90 49 53 58
PANTOPRAZOLE SODIUM 89 52 55 48
SYMBICORT 87 28 56 121
DALIRESP 87 45 56 255
SINGULAIR 86 33 58 67
TRAZODONE HCL 86 43 58 32
CYCLOBENZAPRINE HCL 85 31 R 60 41
EXFORGE 83 45 61 275
PIOGLITAZONE-METFORMIN 83 44 R 10 61 397
POTASSIUM CHLORIDE 81 35 63 11
AMOXICILLIN 77 27 64 113
VOLTAREN 74 40 65 210
RISPERIDONE 73 18 66 74
ALLOPURINOL 72 36 67 36
VYTORIN 69 42 68 154
NAPROXEN 69 26 68 63
TRICOR 67 26 70 103
METOPROLOL SUCCINATE 65 35 71 20
FLUTICASONE PROPIONATE 64 0 72 31
ESCITALOPRAM OXALATE 63 37 73 76
JANUMET 61 59 74 226
PIOGLITAZONE HCL 61 36 R 74 290
VALSARTAN-HYDROCHLOROTHIAZIDE 61 28 74 441
QVAR 61 28 74 329
LANTUS SOLOSTAR 61 38 74 89
COMBIVENT 60 37 79 78
KLOR-CON 10 59 47 80 112
EVISTA 58 35 81 132
IBUPROFEN 57 0 82 70
EXELON 56 49 83 166
AMLODIPINE BESYLATE-BENAZEPRIL 56 43 83 109
ULORIC 55 28 85 342
SERTRALINE HCL 52 30 86 24
FLUCONAZOLE 51 0 87 190
ENALAPRIL MALEATE 51 38 87 75
FLUOXETINE HCL 51 35 87 43
AZITHROMYCIN 50 15 90 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.